XML 16 R33.htm IDEA: XBRL DOCUMENT v3.3.0.814
Commitments and Contingencies (Details Narrative) - USD ($)
1 Months Ended 9 Months Ended
Oct. 22, 2013
Sep. 30, 2014
Sep. 30, 2015
Sep. 19, 2014
Oct. 31, 2013
Sep. 30, 2013
Sep. 05, 2013
Apr. 30, 2013
Apr. 29, 2013
Warrant to purchase shares of common stock       699,671          
Phase 1 Clinical Trial [Member]                  
License commitment fee     $ 25,000            
Due to private placements     25,000            
Phase 3 Clinical Trial [Member]                  
License commitment fee     50,000            
Due to private placements     $ 50,000            
License Agreement [Member]                  
Percentage of commercial sale of the licensed product equal to net sales     3.00%            
Annual minimum royalty for life of the patent rights     $ 25,000            
Payment of UCLA annual maintenance fee     10,000            
Food and drug administration marketing approval     50,000            
Commercial sale amount     25,000            
License commitment fee   $ 100,000              
License Agreement [Member] | UCLA [Member]                  
Percentage of amount raised in private placement 2.00%                
License commitment fee $ 2,500,000                
Due to private placements $ 100,000                
License commitment fee due date Jun. 01, 2014                
Closing II [Member]                  
Payment to acquisition of business     590,000            
Closing III [Member]                  
Private financing debt equity     $ 10,000,000            
Percentage of over allotment option     15.00%            
Warrant to purchase shares of common stock     500,000            
Warrants term     5 years            
Closing IV [Member]                  
Percentage of over allotment option     15.00%            
Closing IV [Member] | Minimum [Member]                  
Public equity transaction in an amount     $ 8,000,000            
Closing IV [Member] | Maximum [Member]                  
Public equity transaction in an amount     $ 10,000,000            
Closing V [Member]                  
Percentage of over allotment option     15.00%            
Initial public offering amount     $ 40,000,000            
Bridge Financing [Member]                  
Principal amount           $ 250,000   $ 300,000  
Note accrued interest rate     12.00%            
Percentage of warrants issued to purchase common stock     50.00%            
Original principal amount price per share     $ 1.00            
Equity securities issued amount     $ 2,500,000            
Bridge Financing [Member] | AFH [Member]                  
Principal amount           $ 50,000      
Bridge Financing [Member] | MTF [Member]                  
Principal amount                 $ 100,000
Bridge Financing [Member] | Orthofix, Corp. [Member]                  
Principal amount         $ 150,000   $ 100,000